Is grade 1 diastolic dysfunction associated with decreased longevity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Grade 1 Diastolic Dysfunction IS Associated with Decreased Longevity

Yes, grade 1 diastolic dysfunction (impaired relaxation pattern) is associated with increased mortality risk and should not be dismissed as a benign age-related finding. The most recent high-quality evidence demonstrates that even isolated grade 1 diastolic dysfunction carries significant prognostic implications for cardiovascular mortality.

Key Evidence from Recent Research

The strongest and most recent evidence comes from a 2025 prospective community-based study that followed 1,005 patients for nearly 20 years 1. This landmark study found that grade 1 diastolic dysfunction was:

  • Common (present in 26% of the community cohort)
  • Associated with 4-fold increased all-cause mortality (HR 4.05,95% CI 3.22-5.09)
  • Associated with 2.4-fold increased cardiovascular mortality even after multivariable adjustment (HR 2.43,95% CI 1.16-5.05)
  • Predictive even in isolated cases: When examining only patients with impaired relaxation and NO other clinical or echocardiographic abnormalities, the mortality risk remained elevated (HR 2.71,95% CI 1.89-3.88) 1

Importantly, this study also found an association with dementia-related death (age- and sex-adjusted HR 2.30), suggesting grade 1 dysfunction may be a biomarker of both cardiovascular and cognitive risk 1.

Reconciling Conflicting Evidence

There is contradictory evidence in the literature that must be addressed:

Studies showing NO increased risk with grade 1:

  • A 2011 large single-center study of 36,261 patients found that mild (grade 1) diastolic dysfunction did NOT affect survival after propensity matching, though moderate and severe dysfunction did 2
  • A 2024 study in HFmrEF patients found grade 1 dysfunction was not associated with long-term mortality 3

Studies showing INCREASED risk with grade 1:

  • A 2013 study demonstrated 2-3 fold increased mortality risk in low-risk adults with grade 1 dysfunction, with incremental prognostic value beyond Framingham risk score 4
  • The 2025 Olmsted County study (most recent and highest quality) 1

Why the 2025 Evidence Should Guide Practice

The 2025 study 1 is superior because it:

  1. Used a well-characterized prospective community cohort (not selected referral populations)
  2. Had exceptionally long follow-up (median 19.7 years)
  3. Specifically examined isolated impaired relaxation patterns
  4. Adjusted for comprehensive confounders
  5. Examined cause-specific mortality (cardiovascular vs. non-cardiovascular)

Guideline Context

The 2016 ASE/EACVI guidelines 5 establish that:

  • Grade 1 dysfunction is defined by E/A ratio ≤0.8 with peak E velocity ≤50 cm/sec
  • Grades 2 and 3 diastolic dysfunction that persist despite medical therapy are highly predictive of worse outcomes
  • The guidelines acknowledge prognostic significance but focus more heavily on advanced grades

The 2024 HFpEF management guidelines 6 note that diagnostic thresholds stem from the 2016 echocardiography recommendations, with key parameters being e', E/e' ratio, left atrial volume index, and tricuspid regurgitation velocity.

Clinical Implications

Grade 1 diastolic dysfunction should trigger:

  1. Aggressive cardiovascular risk factor modification - This is not a benign finding
  2. Closer surveillance for progression to symptomatic heart failure
  3. Consideration of cognitive screening given the association with dementia-related mortality 1
  4. Optimization of blood pressure, lipids, and glycemic control - The 2025 study found associations with these modifiable factors 1

Important Caveats

  • The prognostic significance appears strongest in community-dwelling adults rather than highly selected populations
  • Age matters: While grade 1 dysfunction increases with age, it should not be dismissed as "normal aging" given the mortality associations 1
  • The association with non-cardiovascular death becomes non-significant after adjustment for age and comorbidities, but cardiovascular mortality risk persists 1
  • Outcomes-based thresholds from recent 2026 research suggest mortality risk increases with e' <5.6 cm/s and E/e' >12.4, which may refine risk stratification 7

Bottom line: Grade 1 diastolic dysfunction warrants clinical attention and aggressive risk factor management, not reassurance that it's merely age-related.

References

1
Research

Association of Impaired Relaxation Mitral Inflow Pattern (Grade 1 Diastolic Function) With Long-Term Noncardiovascular and Cardiovascular Mortality.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2025

Related Questions

Is grade 1 diastolic dysfunction concerning?
How can I explain impaired left ventricular diastolic function to an asymptomatic patient?
What is the recommended management for a patient with stage 1 diastolic dysfunction and a dilated left atrium?
In a 73-year-old man with a preserved ejection fraction of 60–65% and grade I diastolic dysfunction, can the diastolic dysfunction improve with appropriate management?
In a patient with a normal‑sized left ventricle, mildly increased wall thickness, moderate septal thickening, moderately increased ventricular mass, reduced ejection fraction of 40‑45 %, and grade I diastolic dysfunction, what are the recommended next steps in management?
In a patient with COPD exacerbation who has a solitary kidney and is already on maintenance prednisone, should I increase the prednisone dose?
What is the recommended piperacillin‑tazobactam dosing for a patient with a glomerular filtration rate of 120 mL/min?
What is the appropriate workup for a patient with a resting tremor?
What is the first‑line antibiotic for cellulitis of the mons pubis in a patient without β‑lactam allergy or MRSA risk?
What compounded intranasal spray regimen (e.g., budesonide combined with azelastine) and adjunct therapies are recommended for chronic sinus inflammation that is refractory to standard treatments?
Are essential oil diffusers safe to use during pregnancy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.